419 related articles for article (PubMed ID: 17485421)
1. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
Mastbergen SC; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
[TBL] [Abstract][Full Text] [Related]
3. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
Studer RK; Georgescu HI; Miller LA; Evans CH
Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
[TBL] [Abstract][Full Text] [Related]
7. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
9. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells.
Mollace V; Colasanti M; Muscoli C; Lauro GM; Iannone M; Rotiroti D; Nistico G
Br J Pharmacol; 1998 Jun; 124(4):742-6. PubMed ID: 9690866
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.
Pacquelet S; Presle N; Boileau C; Dumond H; Netter P; Martel-Pelletier J; Pelletier JP; Terlain B; Jouzeau JY
J Rheumatol; 2002 Dec; 29(12):2602-10. PubMed ID: 12465160
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes.
Henrotin YE; Zheng SX; Deby GP; Labasse AH; Crielaard JM; Reginster JY
J Rheumatol; 1998 Aug; 25(8):1595-601. PubMed ID: 9712106
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures.
Yaron I; Shirazi I; Judovich R; Levartovsky D; Caspi D; Yaron M
Arthritis Rheum; 1999 Dec; 42(12):2561-8. PubMed ID: 10616001
[TBL] [Abstract][Full Text] [Related]
14. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
Van de Loo FA; Arntz OJ; Van den Berg WB
Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
[TBL] [Abstract][Full Text] [Related]
16. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
Mastbergen SC; Bijlsma JW; Lafeber FP
Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
[TBL] [Abstract][Full Text] [Related]
17. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
18. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
Homandberg GA; Hui F
Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
[TBL] [Abstract][Full Text] [Related]
19. Development of selective tolerance to interleukin-1beta by human chondrocytes in vitro.
Lee GM; Tioran ME; Jansen M; Graff RD; Kelley SS; Lin P
J Cell Physiol; 2002 Jul; 192(1):113-24. PubMed ID: 12115742
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
